Robert M. Blankenship

Bob Blankenship served as Chief Financial Officer of NDI Medical from 2005 through 2012, managing the company’s finances, budgets, tax requirements, and transactions. In 2008, Mr. Blankenship along with NDI’s CEO and Chief Counsel were responsible for executing the sale of NDI Medical to Medtronic for $42M. After the sale, Mr. Blankenship and the NDI Executive Team formed the NDI Healthcare Fund raising millions of dollars of capital to invest in new companies using neurostimulation to improve healthcare. Mr. Blankenship continued to operate as NDI’s CFO and served as the acting CFO of each of the portfolio companies that were seeded with capital from the NDI Healthcare Fund. Prior to NDI Medical, Mr. Blankenship spent 20 years in positions of increasing fiscal responsibility with Philips Medical Systems and its predecessors, Marconi Medical Systems and Picker International. In his last position with Philips, Mr. Blankenship was the vice president of finance, managing the worldwide financial functions of the company’s $1.2 billion multi-product business line. In his last years with the company Mr. Blankenship orchestrated and managed the merger of the Marconi Medical and Philips Imaging divisions. The complexities of this merger included the integration of two multinational organizations. Prior to this, Mr. Blankenship was an accountant at Ernst & Young for six years. Mr. Blankenship earned an M.B.A. from Miami University in Oxford, Ohio. He is a certified public accountant.